mskcc.org5d
FDA Approves Zanidatamab for Biliary Tract Cancers With High HER2 Levels
Learn more about a new treatment for biliary tract cancers with high levels of HER2. The drug zanidatamab has been approved ...
mskcc.org1d
How MSK Cares for a Young Woman Living With Stage 4 EGFR Lung Cancer
Learn how a young woman diagnosed with stage 4 non-small cell lung cancer had many treatment options because she came to MSK first.
mskcc.org7d
Cancer-Like Mutations in Healthy Cells Point to Origins of Breast Cancer
Dr. Sohrab Shah's group co-led a multi-institution study into the early genetic origins of breast cancer. Researchers at the ...
mskcc.org13d
Why Active Surveillance Is a Good Option for Many Patients With Papillary Thyroid Cancer
Learn about MSK’s active surveillance program for papillary thyroid cancer, which allows many people to avoid unnecessary surgery and the risks that come with it.
mskcc.org7d
Cancer-Like Mutations in Healthy Cells Point to Origins of Breast Cancer
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
mskcc.org23d
Ivan Maillard Named Head of the Division of Hematologic Malignancies at Memorial Sloan Kettering Cancer Center
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
mskcc.org12d
New Lung Cancer Treatments Aim to Reduce Deaths in 2025 and Beyond
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
mskcc.org6d
Instructions After Your Procedure to Remove Your Implanted Port or Central Venous Catheter (CVC)
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
mskcc.org11d
Peter G. Cordeiro, MD, FACS
Research at MSK Our research impact Research topics Core facilities & resources ...